Short Interest in Sonova Holding (OTCMKTS:SONVY) Decreases By 90.9%

Sonova Holding (OTCMKTS:SONVY) saw a large decline in short interest in the month of February. As of February 27th, there was short interest totaling 1,056 shares, a decline of 90.9% from the February 12th total of 11,643 shares. Approximately 0.0% of the shares of the company are short sold. Based on an average daily trading volume, of 74,022 shares, the short-interest ratio is currently 0.0 days. Based on an average daily trading volume, of 74,022 shares, the short-interest ratio is currently 0.0 days. Approximately 0.0% of the shares of the company are short sold.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on the company. Royal Bank Of Canada raised Sonova to a “moderate buy” rating in a research report on Tuesday, November 18th. Zacks Research raised shares of Sonova from a “strong sell” rating to a “hold” rating in a research report on Monday, February 9th. One research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, four have issued a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold”.

Sonova Price Performance

SONVY stock opened at $51.10 on Wednesday. Sonova has a twelve month low of $47.55 and a twelve month high of $68.76. The business’s 50-day simple moving average is $52.83 and its 200 day simple moving average is $53.77. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.24 and a quick ratio of 0.91.

Sonova Company Profile

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.